DE2818739C2 - Immunologisches Analysenverfahren - Google Patents
Immunologisches AnalysenverfahrenInfo
- Publication number
- DE2818739C2 DE2818739C2 DE2818739A DE2818739A DE2818739C2 DE 2818739 C2 DE2818739 C2 DE 2818739C2 DE 2818739 A DE2818739 A DE 2818739A DE 2818739 A DE2818739 A DE 2818739A DE 2818739 C2 DE2818739 C2 DE 2818739C2
- Authority
- DE
- Germany
- Prior art keywords
- deep
- carrier
- antibody
- bound
- immunoglobulin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004458 analytical method Methods 0.000 title claims description 4
- 230000001900 immune effect Effects 0.000 title claims description 4
- 108060003951 Immunoglobulin Proteins 0.000 claims description 28
- 102000018358 immunoglobulin Human genes 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 24
- 239000000376 reactant Substances 0.000 claims description 16
- 229940072221 immunoglobulins Drugs 0.000 claims description 13
- 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 claims description 12
- 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 claims description 12
- 238000003776 cleavage reaction Methods 0.000 claims description 10
- 230000007017 scission Effects 0.000 claims description 10
- 238000002372 labelling Methods 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000012488 sample solution Substances 0.000 claims description 2
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims 1
- 229940027941 immunoglobulin g Drugs 0.000 claims 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 16
- 239000002953 phosphate buffered saline Substances 0.000 description 16
- 239000000243 solution Substances 0.000 description 13
- 230000000295 complement effect Effects 0.000 description 10
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 8
- 229940098773 bovine serum albumin Drugs 0.000 description 8
- 238000009739 binding Methods 0.000 description 7
- 239000000427 antigen Substances 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 229920001213 Polysorbate 20 Polymers 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000424725 Heide Species 0.000 description 2
- 108010093096 Immobilized Enzymes Proteins 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 230000004154 complement system Effects 0.000 description 2
- -1 cyclic acetals Chemical class 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 102000013415 peroxidase activity proteins Human genes 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 125000005289 uranyl group Chemical group 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- PNDPGZBMCMUPRI-HVTJNCQCSA-N 10043-66-0 Chemical compound [131I][131I] PNDPGZBMCMUPRI-HVTJNCQCSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- 208000024781 Immune Complex disease Diseases 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 235000020004 porter Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (18)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2818739A DE2818739C2 (de) | 1978-04-28 | 1978-04-28 | Immunologisches Analysenverfahren |
| ES471585A ES471585A1 (es) | 1977-07-15 | 1978-07-10 | Procedimiento para la determinacion de reactivos fc |
| CH7601/78A CH649306A5 (de) | 1977-07-15 | 1978-07-12 | Traegergebundenes immunglobulin-spaltprodukt und seine verwendung fuer immunologische analysenverfahren. |
| NL7807563A NL7807563A (nl) | 1977-07-15 | 1978-07-13 | Drager-gebonden immuno-globuline-splitsingsproduct en de toepassing daarvan voor immunologische analyse- -werkwijzen. |
| IT25665/78A IT1097225B (it) | 1977-07-15 | 1978-07-13 | Prodotto di scissione di immunoglobulina supportato e suo impiego per processi analitici immunologici |
| NZ187848A NZ187848A (en) | 1977-07-15 | 1978-07-13 | Carrier-bound immunoglobulin fission product and its use in immunologic analyses |
| US05/924,283 US4239743A (en) | 1977-07-15 | 1978-07-13 | Carrier-bound immunoglobulin fission product and its use in immunologic analyses |
| LU79974A LU79974A1 (de) | 1977-07-15 | 1978-07-13 | Immunologisches analysenverfahren durch verwendung eines traegergebundenen immunglobulin-spaltproduktes |
| AU38007/78A AU516906B2 (en) | 1977-07-15 | 1978-07-13 | Immunoglobulin conjugate |
| AT0511178A AT366180B (de) | 1977-07-15 | 1978-07-14 | Verfahren und reagens zur immunologischen bestimmung von fc-reaktanten |
| DK783179A DK317978A (da) | 1977-07-15 | 1978-07-14 | Baererbundet spaltningsprodukt af et immunglobulin samt dets anvendelse |
| CA000307421A CA1117009A (en) | 1977-07-15 | 1978-07-14 | Fc fragment of immunoglobulin bound to a carrier |
| GB7829871A GB2001171B (en) | 1977-07-15 | 1978-07-14 | Carrier bound immunoglobulin fission product and its use use in immumologic analyses |
| IE1416/78A IE47031B1 (en) | 1977-07-15 | 1978-07-14 | Carrier-bound immunoglobulin fission product and its use in immunologic analyses |
| SE787807849A SE7807849L (sv) | 1977-07-15 | 1978-07-14 | Berarbunden immunglobulin-spaltprodukt och dess anvendning for immunologiska analysforfaranden |
| JP8569478A JPS5444009A (en) | 1977-07-15 | 1978-07-15 | Immune globulin decomposed substance bound to carrier and use thereof in immunological analytic method |
| FR7821194A FR2397423A1 (fr) | 1977-07-15 | 1978-07-17 | Produit de scission des immunoglobulines lie a un support et son utilisation dans les procedes d'analyse immunologique |
| ES474871A ES474871A1 (es) | 1977-07-15 | 1978-11-07 | Procedimiento para la determinacion de inmunoglobulina inmu-nologicamente modificada. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2818739A DE2818739C2 (de) | 1978-04-28 | 1978-04-28 | Immunologisches Analysenverfahren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2818739A1 DE2818739A1 (de) | 1979-11-08 |
| DE2818739C2 true DE2818739C2 (de) | 1987-01-15 |
Family
ID=6038263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2818739A Expired DE2818739C2 (de) | 1977-07-15 | 1978-04-28 | Immunologisches Analysenverfahren |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE2818739C2 (US20080094685A1-20080424-C00004.png) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2731992A1 (de) * | 1977-07-15 | 1979-02-01 | Behringwerke Ag | Verfahren zur bestimmung von immunologisch veraendertem immunglobulin |
-
1978
- 1978-04-28 DE DE2818739A patent/DE2818739C2/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE2818739A1 (de) | 1979-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0008432B1 (de) | Immunologisches Bestimmungsverfahren | |
| DE3854194T2 (de) | Monoklonale antikörper gegen glykosyliertes albumin, hybride zellinien, die diese antikörper produzieren, sowie deren verwendung. | |
| DK160108C (da) | Fremgangsmåde og udstyr til direkte eller indirekte påvisning af reaktion mellem et specifikt bindingsmiddel og den tilsvarende acceptorsubstans | |
| JP3108103B2 (ja) | ヒト心筋ミオグロビンに対するモノクローナル抗体 | |
| JP2009020120A (ja) | 動物において早期腎疾患を検出する方法 | |
| AU652598B2 (en) | Diagnostic method for detecting the rupture of fetal membranes and test kit employing the method | |
| JPH10511185A (ja) | 胸痛の発症初期に診断し鑑別するための方法ならびに装置 | |
| CA1195925A (en) | Method for assaying antigen-antibody reactions and reagent therefor | |
| DE3209149A1 (de) | Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum | |
| CH649306A5 (de) | Traegergebundenes immunglobulin-spaltprodukt und seine verwendung fuer immunologische analysenverfahren. | |
| EP0292810A2 (de) | Einschritt-Immuntest zur Bestimmung von antigen-spezifischen Antikörpern aus einer der Immunglobulin-Klassen A, M, D oder E und dazu geeignetes Mittel | |
| EP0291086B1 (de) | Verfahren zur Bestimmung eines Antikörpers in menschlichen Körperflüssigkeiten | |
| EP0782585B1 (de) | RHEUMAFAKTOR-ENTSTÖRUNG MIT ANTI-Fd-ANTIKÖRPERN | |
| DE2952478A1 (de) | Verfahren und mittel zur immunologischen bestimmung von enzymen | |
| EP0379216B1 (de) | Verfahren und Reagenz zur Bestimmung von immunologisch nachweisbaren Substanzen | |
| DE69733957T2 (de) | Verfahren zur bestimmung der gegenwart des gehirnspezifischen proteins s-100 beta | |
| DE68922796T2 (de) | Element und verfahren zum nachweis des rheumatoidfaktors. | |
| Ingerslev et al. | Enzyme linked immunosorbent assay (ELISA) for the measurement of factor VIII coagulant antigen (CAg) using haemophilic antibodies | |
| DE2818739C2 (de) | Immunologisches Analysenverfahren | |
| EP0345732A2 (de) | Verfahren zur Bestimmung eines Antikörpertiters | |
| EP0554657B1 (de) | Verfahren zur Bestimmung von Antigenen oder Antikörpern in Gegenwart eines Immunkomplexes | |
| AU630865B2 (en) | Measurement of transferrin | |
| DE68911574T2 (de) | Reagenzsystem zur Bestimmung des Komplexes des menschlichen Plasminogenaktivator-Inhibitors und des menschlichen Gewebeplasminogenaktivators und Testsatz dafür. | |
| DE3854603T2 (de) | Teststreifen für diagnose durch multi-immunoassay system. | |
| EP1393076A2 (de) | Verfahren zur vorhersage eines transplantatabstossungsrisikos und immunologischer testkit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8330 | Complete renunciation |